MktsMarkets

Privia Health Group, Inc.
NASDAQ: PRVAKey statistics
PRVA News
Stories mentioning PRVA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 596,425 | 529,895 | 566,016 | 517,817 | 474,879 | 455,652 | 432,108 | 417,228 |
| Operating Income (Loss) | 7,422 | 11,278 | 14,403 | 3,336 | 5,218 | 5,248 | 5,813 | 5,098 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 9,310 | 13,371 | 16,674 | 5,744 | 8,149 | 8,022 | 7,977 | 8,064 |
| Tax Provision | 5,600 | 2,786 | 6,867 | 2,456 | 2,103 | 2,655 | 3,999 | 3,421 |
| Net Income (Loss) | 3,064 | 9,151 | 6,861 | 2,687 | 4,220 | 4,399 | 3,535 | 3,467 |
| Earnings Per Share (Basic) | 0.02 | 0.07 | 0.06 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 |
| Earnings Per Share (Diluted) | 0.02 | 0.07 | 0.05 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 |
| Weighted Average Shares Outstanding (Basic) | 124,153 | 122,177 | 122,769 | 122,132 | 120,624 | 119,403 | 119,659 | 119,301 |
| Weighted Average Shares Outstanding (Diluted) | 130,879 | 128,890 | 128,777 | 128,447 | 127,753 | 125,614 | 125,751 | 125,318 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PRVA
Privia Health Group, Inc. (NASDAQ: PRVA) is a stock listed on the Nasdaq Stock Market under the ticker symbol PRVA. It last traded at $22.00 (Oct 29, 2026, 4:00 PM ET), up 0.7% on the day. That gives Privia Health a market capitalisation of $2.8B and a price-to-earnings ratio of 99.9.
Over the past 52 weeks PRVA has traded between $18.91 and $28.82.
Net income for the quarter ended Mar 31, 2026 was $3.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | $3.1M |
| Dec 31, 2025 | — | $9.2M |
| Sep 30, 2025 | — | $6.9M |
| Jun 30, 2025 | — | $2.7M |
From Privia Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…